ASRT Assertio Holdings Inc.

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025

LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial results on Monday, August 11, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide business updates on the Company’s 2025 strategic plans.

To access the live webcast, conference call information, and other materials, please visit Assertio’s investor relations website at . Please connect at least 10 minutes prior to the live webcast to ensure adequate time for any software download that may be needed to access the webcast. For those wishing to join by telephone only, please dial . The call ID is 3278948.

A webcast replay of the call will be available approximately two hours after the call on Assertio’s investor website.

About Assertio

Assertio is a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs. Our focus is on supporting patients by marketing products in oncology, neurology, and pain management. To learn more about Assertio, visit .

Investor Contact

Matt Kreps

Darrow Associates Investor Relations



  



EN
05/08/2025

Underlying

ASRTAssertio Holdings Inc.

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Assertio Holdings Inc.

 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Reports Second Quarter 2025 Financial Results

Assertio Reports Second Quarter 2025 Financial Results Second Quarter Total Net Product Sales of $28.8 Million, Cash and Investments Increase to $98.2 Million Narrows Guidance on Continued Progress Implementing Long-Term Business Strategy LAKE FOREST, Ill., Aug. 11, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the second quarter ended June 30, 2025. Said Brendan O...

August 11, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Result...

Assertio Holdings, Inc. to Report Second Quarter 2025 Financial Results on August 11, 2025 LAKE FOREST, Ill., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release second quarter 2025 financial results on Monday, August 11, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and provide business updates on the Company’s 2025 strategic plans. To access the live webcast, conference call inform...

August 5, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio to Participate in the Alliance Global Partners Healthcare Com...

Assertio to Participate in the Alliance Global Partners Healthcare Company Showcase on May 21, 2025 LAKE FOREST, Ill., May 19, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that Brendan O’Grady, Chief Executive Officer, will present at the virtual Alliance Global Partners Healthcare Company Showcase, taking place Wednesday, May 21, 2025. Mr. O’Grady’s fireside chat will be webcast live at 11:20 a.m. ET. To join the event, please register at , or visit the Events & Presentations page at the Company’s investor relations websit...

May 19, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Reports First Quarter 2025 Financial Results

Assertio Reports First Quarter 2025 Financial Results First Quarter Total Net Product Sales of $26.0 Million, In Line with 2025 Outlook Provides Update on Long-Term Business Strategy Designed to Create Sustainable Near-Term Growth and Increased Long-Term Value LAKE FOREST, Ill., May 12, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT), a pharmaceutical company with comprehensive commercial capabilities offering differentiated products designed to address patients’ needs, today reported financial results for the first quarter ende...

May 12, 2025 1 EN
 PRESS RELEASE
Free
ASRT Assertio Holdin...

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results...

Assertio Holdings, Inc. to Report First Quarter 2025 Financial Results on May 12, 2025 LAKE FOREST, Ill., May 05, 2025 (GLOBE NEWSWIRE) -- Assertio Holdings, Inc. (“Assertio” or the “Company”) (Nasdaq: ASRT) today announced that it will release first quarter 2025 financial results on Monday, May 12, 2025, after the market close. Additionally, Assertio’s management will host a live webcast conference call at 4:30 p.m. Eastern Time to discuss the financial results and update the Company’s 2025 strategic plans. To access the live webcast, conference call information, and other materials, ...

May 5, 2025 1 EN

ResearchPool Subscriptions

Get the most out of your insights

Get in touch